Shan Lin, MD, speaks to the new MIGS entering the glaucoma space and providing additional options for patients and providers ...

VAUGHAN, Ontario - Bausch + Lomb Corporation (NYSE/TSX: BLCO), a prominent eye health company with a market capitalization of $6.25 billion, has announced the conclusion of its search for a ...

Himani Goyal, MD, takes glaucoma care to the next level by embracing advancements that extend beyond traditional treatment ...

Qlaris Bio, Inc., a clinical-stage biotechnology company targeting unmet needs in debilitating ophthalmic diseases, today announced positive topline results from two U.S. Phase II clinical trials ...

In this Healio Video Perspective from Hawaiian Eye 2025, I. Paul Singh, MD, explains excimer laser trabeculostomy for the ...

You may have heard the term “glaucoma” before, but what is it really, and how do you know if you have it? Glaucoma is an eye disease in which the optic nerve is damaged over time due to elevated ...

Piper Sandler analyst Matt O'Brien increased the price target for Glaukos Corporation (NYSE:GKOS) shares to $180 from the previous target of $140, while maintaining an Overweight rating on the stock.

Piper Sandler analyst Matt O’Brien raised the firm’s price target on Glaukos (GKOS) to $180 from $140 and keeps an Overweight rating on the ...

An eye doctor's main goal in the treatment of glaucoma is to lower eye pressure to a safe level in order to halt damage caused by the high-pressure levels. Treatment typically includes prescribing ...

Minimally invasive glaucoma surgeries (MIGS) have become increasingly popular because they are safer and require less recovery time. These procedures use tiny devices to improve fluid drainage and ...